Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/11/15 → 8/11/18 |
Funding
- PPD Development (Prot #GS-US-384-1497 // Prot #GS-US-384-1497)
- Gilead Sciences, Inc (Prot #GS-US-384-1497 // Prot #GS-US-384-1497)
Prot #GS-US-384-1497: A Phase 2, Randomized, Open Label Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 alone or in Combination with Simtuzumab (SIM) in Subjects with Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3
- Rinella, Mary Eugenia (PD/PI)
Project: Research project